528 related articles for article (PubMed ID: 8200083)
41. Developmental changes in hepatic activation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in rabbit.
Rich KJ; Zhao K; Davies DS; Boobis AR; Gooderham NJ
Carcinogenesis; 1996 Mar; 17(3):555-8. PubMed ID: 8631144
[TBL] [Abstract][Full Text] [Related]
42. Glucuronidation of N-hydroxy heterocyclic amines by human and rat liver microsomes.
Kaderlik KR; Mulder GJ; Turesky RJ; Lang NP; Teitel CH; Chiarelli MP; Kadlubar FF
Carcinogenesis; 1994 Aug; 15(8):1695-701. PubMed ID: 8055651
[TBL] [Abstract][Full Text] [Related]
43. Potent antimutagenic activity of white tea in comparison with green tea in the Salmonella assay.
Santana-Rios G; Orner GA; Amantana A; Provost C; Wu SY; Dashwood RH
Mutat Res; 2001 Aug; 495(1-2):61-74. PubMed ID: 11448643
[TBL] [Abstract][Full Text] [Related]
44. The inhibition by flavonoids of 2-amino-3-methylimidazo[4,5-f]quinoline metabolic activation to a mutagen: a structure-activity relationship study.
Edenharder R; Rauscher R; Platt KL
Mutat Res; 1997 Sep; 379(1):21-32. PubMed ID: 9330619
[TBL] [Abstract][Full Text] [Related]
45. Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by human cytochrome P4501A1, P4501A2 and P4501B1.
Crofts FG; Sutter TR; Strickland PT
Carcinogenesis; 1998 Nov; 19(11):1969-73. PubMed ID: 9855011
[TBL] [Abstract][Full Text] [Related]
46. Molecular cloning and functional analysis of cynomolgus monkey CYP1A2.
Sakuma T; Hieda M; Igarashi T; Ohgiya S; Nagata R; Nemoto N; Kamataki T
Biochem Pharmacol; 1998 Jul; 56(1):131-9. PubMed ID: 9698097
[TBL] [Abstract][Full Text] [Related]
47. Cytotoxicity, DNA adduct formation and DNA repair induced by 2-hydroxyamino-3-methylimidazo[4,5-f]quinoline and 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine in cultured human mammary epithelial cells.
Fan L; Schut HA; Snyderwine EG
Carcinogenesis; 1995 Apr; 16(4):775-9. PubMed ID: 7728954
[TBL] [Abstract][Full Text] [Related]
48. Heterocyclic aromatic amines induce DNA strand breaks and cell transformation.
Pfau W; Martin FL; Cole KJ; Venitt S; Phillips DH; Grover PL; Marquardt H
Carcinogenesis; 1999 Apr; 20(4):545-51. PubMed ID: 10223180
[TBL] [Abstract][Full Text] [Related]
49. Enzyme-kinetic and immunochemical characteristics of mouse cDNA-expressed, microsomal, and purified CYP1A1 and CYP1A2.
Tsyrlov IB; Goldfarb IS; Gelboin HV
Arch Biochem Biophys; 1993 Dec; 307(2):259-66. PubMed ID: 8274012
[TBL] [Abstract][Full Text] [Related]
50. Regioselective differences in C(8)- and N-oxidation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline by human and rat liver microsomes and cytochromes P450 1A2.
Turesky RJ; Parisod V; Huynh-Ba T; Langouët S; Guengerich FP
Chem Res Toxicol; 2001 Jul; 14(7):901-11. PubMed ID: 11453738
[TBL] [Abstract][Full Text] [Related]
51. The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes.
Ueng YF; Jan WC; Lin LC; Chen TL; Guengerich FP; Chen CF
Drug Metab Dispos; 2002 Mar; 30(3):349-53. PubMed ID: 11854157
[TBL] [Abstract][Full Text] [Related]
52. Modulation of rat liver cytochrome P450 by protein restriction assessed by biochemical and bacterial mutagenicity methods [corrected].
Cancino-Badías L; Reyes RE; Nosti R; Pérez I; Dorado V; Caballero S; Soria A; Camacho-Carranza R; Escobar D; Espinosa-Aguirre JJ
Mutagenesis; 2003 Jan; 18(1):95-100. PubMed ID: 12473742
[TBL] [Abstract][Full Text] [Related]
53. Metabolic activation of heterocyclic amine food mutagens in the mammary gland of lactating Fischer 344 rats.
Davis CD; Ghoshal A; Schut HA; Snyderwine EG
Cancer Lett; 1994 Aug; 84(1):67-73. PubMed ID: 7915639
[TBL] [Abstract][Full Text] [Related]
54. Metabolism of heterocyclic aromatic amines and strategies of human biomonitoring.
Turesky RJ; Fay LB; Welti DH
Princess Takamatsu Symp; 1995; 23():59-68. PubMed ID: 8844796
[TBL] [Abstract][Full Text] [Related]
55. Effect of high sucrose diet on cytochrome P450 1A and heterocyclic amine mutagenesis.
Peters LP; Teel RW
Anticancer Res; 2003; 23(1A):399-403. PubMed ID: 12680239
[TBL] [Abstract][Full Text] [Related]
56. Metabolic activation of a protein pyrolysate promutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline by rat liver microsomes and purified cytochrome P-450.
Yamazoe Y; Abu-Zeid M; Manabe S; Toyama S; Kato R
Carcinogenesis; 1988 Jan; 9(1):105-9. PubMed ID: 3121205
[TBL] [Abstract][Full Text] [Related]
57. Metabolism of the food derived mutagen and carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP) by human liver microsomes.
Zhao K; Murray S; Davies DS; Boobis AR; Gooderham NJ
Carcinogenesis; 1994 Jun; 15(6):1285-8. PubMed ID: 8020169
[TBL] [Abstract][Full Text] [Related]
58. Constitutive and inducible levels of CYP1A1 and CYP1A2 in rat cerebral cortex and cerebellum.
Iba MM; Storch A; Ghosal A; Bennett S; Reuhl KR; Lowndes HE
Arch Toxicol; 2003 Oct; 77(10):547-54. PubMed ID: 14574441
[TBL] [Abstract][Full Text] [Related]
59. Induction of cytochrome P4501A1 by aryl hydrocarbon receptor agonists in porcine aorta endothelial cells in culture and cytochrome P4501A1 activity in intact cells.
Stegeman JJ; Hahn ME; Weisbrod R; Woodin BR; Joy JS; Najibi S; Cohen RA
Mol Pharmacol; 1995 Feb; 47(2):296-306. PubMed ID: 7870038
[TBL] [Abstract][Full Text] [Related]
60. Intra- and interindividual variability in systemic exposure in humans to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline and 2-amino-1-methyl- 6-phenylimidazo[4,5-b]pyridine, carcinogens present in cooked beef.
Lynch AM; Knize MG; Boobis AR; Gooderham NJ; Davies DS; Murray S
Cancer Res; 1992 Nov; 52(22):6216-23. PubMed ID: 1423264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
